Images in Pulmonary MedicineAsymptomatic Reactivation of Endobronchial Mycobacterium tuberculosis Found Incidentally During Esophageal Carcinoma RestagingBoyd, Michael MD; Boyd, Trudy BSNAuthor Information Virginia Tech Carilion School of Medicine, Section of Pulmonary, Critical Care, Environmental, and Sleep Medicine, Carilion Clinic, Roanoke, VA The authors declare that they have nothing to disclose. Address correspondence to: Michael Boyd, MD, Virginia Tech Carilion School of Medicine, Section of Pulmonary, Critical Care, Environmental, and Sleep Medicine, Carilion Clinic, 1906 Belleview Ave., Roanoke, VA 24014. E-mail: [email protected]. Clinical Pulmonary Medicine: September 2012 - Volume 19 - Issue 5 - p 240-242 doi: 10.1097/CPM.0b013e31826707b0 Buy Metrics Abstract Neoadjuvant chemotherapy for esophageal malignancy requires appropriate restaging before a decision regarding definitive therapy with esophagectomy. Clinical restaging with positron emission tomography-computed tomography, although sensitive, is not specific. It is recommended that any abnormal findings at positron emission tomography-computed tomography be confirmed pathologically. We present a patient that supports this recommendation and highlights that even nonmalignant findings can present a challenge regarding treatment decisions for cancer patients. This may be particularly true for patients residing in areas endemic for Mycobacterium tuberculosis. We present a patient with reactivation endobronchial tuberculosis while undergoing chemoradiation for squamous cell esophageal malignancy, and illustrate the subsequent treatment decisions that resulted. © 2012 Lippincott Williams & Wilkins, Inc.